Your browser doesn't support javascript.
loading
Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.
Labidi-Galy, S Intidhar; Olivier, Timothée; Rodrigues, Manuel; Ferraioli, Domenico; Derbel, Olfa; Bodmer, Alexandre; Petignat, Patrick; Rak, Beata; Chopin, Nicolas; Tredan, Olivier; Heudel, Pierre-Etienne; Stuckelberger, Sarah; Meeus, Pierre; Meraldi, Patrick; Viassolo, Valeria; Ayme, Aurélie; Chappuis, Pierre O; Stern, Marc-Henri; Houdayer, Claude; Stoppa-Lyonnet, Dominique; Buisson, Adrien; Golmard, Lisa; Bonadona, Valérie; Ray-Coquard, Isabelle.
Affiliation
  • Labidi-Galy SI; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland. intidhar.labidi-galy@hcuge.ch.
  • Olivier T; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Rodrigues M; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • Ferraioli D; Inserm U830, PSL Research University, Institut Curie, Paris, France.
  • Derbel O; Department of Surgery, Centre Léon Bérard, Lyon, France.
  • Bodmer A; Institut du Cancer Jean Mermoz, Lyon, France.
  • Petignat P; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Rak B; Department of Gynecology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Chopin N; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Tredan O; Department of Surgery, Centre Léon Bérard, Lyon, France.
  • Heudel PE; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Stuckelberger S; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Meeus P; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Meraldi P; Department of Surgery, Centre Léon Bérard, Lyon, France.
  • Viassolo V; Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Ayme A; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Chappuis PO; Department of Genetic, Laboratory and Pathology Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Stern MH; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Houdayer C; Department of Genetic, Laboratory and Pathology Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Stoppa-Lyonnet D; Inserm U830, PSL Research University, Institut Curie, Paris, France.
  • Buisson A; Division of Genetics, Pôle de Médecine diagnostique et théranostique, Institut Curie, Paris, France.
  • Golmard L; Inserm U830, PSL Research University, Institut Curie, Paris, France.
  • Bonadona V; Division of Genetics, Pôle de Médecine diagnostique et théranostique, Institut Curie, Paris, France.
  • Ray-Coquard I; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Clin Cancer Res ; 24(2): 326-333, 2018 01 15.
Article in En | MEDLINE | ID: mdl-29084914
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor / BRCA2 Protein / Mutation Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Switzerland Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor / BRCA2 Protein / Mutation Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Switzerland Country of publication: United States